drug studyfgsd5yef
TRANSCRIPT
-
7/29/2019 Drug StudyFGSD5YEF
1/9
DRUG STUDY
DOSAGE /
ROUTE /
FREQUENCY
MECHANIS
MOF
ACTION
INDICATIONS CONTRAINDICATION
S
SIDE EFFECTS
NURSING
CONSIDERATIONS
GenericName:
Bisacodyl
Brand Name:
Dulcolax
- 10mg 2tabs
- Oral- OD - HS
Increasesperistalsis& motoractivity ofthe smallintestines
by actingdirectly onthe smoothmuscles.
Constipation Evacuation of
bowel beforeradiologicstudies orsurgery
Acutesurgicalabdomen orintestinalobstruction
severedehydration
fecalimpaction
chronic use.
Abdominalcramps (colic,cramps)
Nausea Diarrhea Hypokalemia Muscle
weakness
Assess bowelsounds
Do not give ifpatient ahsabdominal pain
Teach the patient:
short-termtherapyonly
increasefluidintake
bulk up thediet
normalbowelhabits mayvary from3times/day
to3 times/week
Classification:
- laxatives
-
7/29/2019 Drug StudyFGSD5YEF
2/9
DRUG
DOSAGE /
ROUTE /FREQUENCY
MECHANISM
OF ACTION INDICATIONS CONTRAINDICATIONS SIDEEFFECTS
NURSING
CONSIDERATIONS
Generic
Name:Cefuroxime
Brand Name:
- 750mg- IV- q 8 hrs
Second-
generationcephalosporinthat inhibits
cell-wallsynthesis,
promotingosmoticinstability;usually
bactericidal.
- Preoperativeprophylaxis inclients
undergoingsurgical
proceduresclassified ascleancontaminated or
potentiallycontaminated.
* Contraindicated inpatients hypersensitive todrug.
* Use cautiously inpatients hypersensitive topenicillin because ofpossibility of cross-sensitivity with other
beta-lactam antibiotics.
GI:Diarrhea,
nausea,
antibiotic-associatedcolitis.
Skin:Rash,
pruritus,urticaria.
Urogenital:Increasedserumcretonneand BUN,decreasedcreatinineclearance
1. Check fordoctors
order
2. Perform ANST prior to
admission
3. Should not be given
if positive skin test
4. Slow IV push
5. Inform the patient about
the possible side effect of
the drug
6. Advise patient toreport any discomfort
on the IV insertion site.
Classification:
2ndgenerationCephalosporin
-
7/29/2019 Drug StudyFGSD5YEF
3/9
DRUGDOSAGE /ROUTE /
FREQUENCY
MECHANISMOF ACTION INDICATIONS CONTRAINDICATIONS SIDE
EFFECTS
NURSINGCONSIDERATIONS
Generic Name:
Ketorolac
Brand Name:Toradol
- 30mg(3doses)
- IV- q 6hrs
Reduces the
productionof
prostaglandins,chemicals thatcells of the
immune systemmake thatcause theredness, fever,
and pain ofinflammationand that also are
believedto be importantin the
production ofnoninflammatory
pain.
For short term
management(up to 5 days)
of moderatelysevere acute
pain that
otherwisewould requirenarcotics. Itmost often is
used aftersurgery.
Hypersensitivity
to ketorolac, renalImpairment, aspirin
allergy
> Rash
> Ringing inthe
ears> Headaches> Dizziness
> Drowsiness> Abdominal
pain> Nausea
> Diarrhea> Constipation> Heartburn> Fluidretention> Somnolence
1. Assess patient for
contraindication.2. Assess for baseline
data.3. Infuse slowly as a
bolus over
no less than 15seconds.4. Tell patient that hemay
experience sideeffects
brought upon by thedrug.5. Provide comfortmeasures ifheadache occurs.
Classification:Nonsteroidalanti-inflammatorydrug
-
7/29/2019 Drug StudyFGSD5YEF
4/9
DRUG
DOSAGE /
ROUTE /FREQUENCY
MECHANISM
OF ACTION INDICATIONS CONTRAINDICATIONS SIDE EFFECTS
NURSING
CONSIDERATIONS
Generic Name:
Bupivacaine
Brand Name:Bupican
Bupivacaine
0.25% 10cc +0.25MSO4 OD
> Block the
generation andthe conductionof nerve
impulses,presumably byincreasing thethreshold forelectricalexcitation in thenerve, byslowing the
propagation ofthe nerveimpulse, and byreducingthe rate of riseof the action
potential.> The analgesiceffects of
Bupivacaine arethought to
be due to itsbinding to theprostaglandinE2 receptors,subtype EP1(PGE2EP1),
which inhibitsthe
production of
> Local or
regionalanesthesia> Analgesia
for surgery
> Hypersensitivity
to bupivacaine orother localanesthesia e.g.
lignocaine, bloodclotting disorder,low blood pressure,
> Nervousness
> Tinglingaround themouth
> Tinnitus> Tremor> Dizziness> Blurred vision> Ringing of theears> Feeling ofdisorientation
> Nausea> Vomiting> Drowsiness> Numbness oftongue>Lightheadedness
1. Assess for
contraindication.2. Assess for baselinedata.
3. Monitor vital signscarefully,drug depresses the
pulmonaryand cardiac system.4. Monitor for sideeffects.5. Tell patient that he
mayexperience sideeffects
brought about by thedrug andif such is/areintolerable hemust report them soas prompt
interventions bedone.
6. Oral care ifvomiting occurs.7. Monitor foroccurrence ofadverse effects,report to the
anesthesiologist anysigns andsymptoms of adverse
Classification:Anesthesia
-
7/29/2019 Drug StudyFGSD5YEF
5/9
prostaglandins,
therebyreducing fever,inflammation,
and
effects.
8. Continue tomonitor patientfollowing
discontinuation of
anesthesia.
-
7/29/2019 Drug StudyFGSD5YEF
6/9
DRUG
DOSAGE /
ROUTE /FREQUENCY
MECHANISM
OF ACTION INDICATIONS CONTRAINDICATIONS SIDEEFFECTS
NURSING
CONSIDERATIONS
Generic Name:
NalbuphineHCL
Brand Name:Nubain
- 5mg- IM
Binds with
opiate receptorsin the CNS,altering
perception ofand emotionalresponse to pain.
Management of
moderate tosevere painpreoperative
andpostoperativeanalgesiasupplement to
balancedanesthesia
Contraindicated in
patients hypersensitive todrugUse cautiously in
patients with history ofdrug abuse and in thosewith emotional instability,head injury, increasedICP, impaired ventilation,MI accompanied by N/V,upcoming biliary surgery,and hepatic or renal
disease
CNS:Sedation,dizziness,vertigo,headache,
agitation,confusion,crying,
depression,dysphoria,
euphoria,faintness,floating feeling,hallucinations,heavinessfeeling,hostility,nervousness,numbness,restlessness,seizures,tingling,unreality,unusual dreams
CV:Bradycardia,hypertension,hypotension,tachycardia
Reassesspatients
level of pain at least15 and 30 minutesafter parenteral
administrationNalbuphine acts asan opioid antagonistand may causewithdrawalsyndrome. For
patients who havereceived log-term
opioids, give 25% ofthe usual doseinitially. Watch forsings of withdrawal.Alert: Drug causesrespiratorydepression, which at10mg is equal torespiratory
depression producedby 10 mg of
morphineMonitor circulatory
and respiratorystatus, bladder and
bowel function. Ifrespirations are
shallow or rate isbelow 12breaths/minute,
Classification:
Narcotic agonist-antagonistanalgesic
-
7/29/2019 Drug StudyFGSD5YEF
7/9
EENT: Blurred
vision, drymouth
GI: Nausea,
vomiting,biliary tractspasms,
constipationcramps,dyspepsia
GU: Urinaryurgency
Respiratory:Respiratorydepression,asthma,
dyspnea,pulmonary
edema
Skin: Burning,clamminess,diaphoresis,
pruritus,uticaria
withhold dose and
notify prescriberConstipation isoften severe with
maintenance therapy.
Make sure stoolsoftener or otherlaxative is ordered.Psychological and
physical dependencemay occur with
prolonged use.
-
7/29/2019 Drug StudyFGSD5YEF
8/9
DRUG
DOSAGE /
ROUTE /FREQUENCY
MECHANIS
MOF ACTION
INDICATIONS CONTRAINDICATIONS
SIDE EFFECTS
NURSING
CONSIDERATIONS
Generic Name:Promethazinehydrochloride
Brand Name:Phenergan
- 25mg- IM Selectivelyblocks H1
receptors,
diminishingthe effects ofhistamine oncells of theupperrespiratorytract and eyesand
decreasing thesneezing,mucus
production,itching andtearing thataccompanyallergicreactions in
sensitizedpeople
exposed toantigens;
blockscholinergicreceptors inthe vomiting
center that arebelieved tomediate
Treatmentand
prevention
of motionsickness;
preventionand controlof nauseaandvomitingassociated
withanesthesiaand surgery.
Preoperative,
postoperative orobstetric
sedation.
Adjunct toanalgesicsto control
postoperative pain.
hypersensitivity toantihistamines or
phenothiazines, coma or
severe CNS depression,bone marrow depression,vomiting of unknowncause, concomitanttherapy with MAOIs,lactation.
CNS: Dizziness,Drowsiness, poorcoordination,
confusion,restlessness,excitation,convulsions,tremors, headache,
blurred vision,diplopia, vertigo,tinnitur
CV: Hypotension,palpitations,bradycardia,tachycardia,extrasystoles
DERMATOLOGIC: Urticaria, rash,
photosensitivity,chills.
GI: Epigastricdistress, nausea,vomiting, diarrhea,constipation
GU: Urinaryfrequency, dysuria,urinary retention,
Observe 10 rights indrug administration.
Assess forhypersensitivity andothercontraindication.
Classification:Phenothiazine,Dopaminergic
bloking agent,Antihistamine,Antiemetic, Anti-motion sicknessagent,Sedative/hypnotic.
-
7/29/2019 Drug StudyFGSD5YEF
9/9
nausea and
vomitingcaused bygastric
irritation, by
input from thechemoreceptor trigger zone;depress the
RAS,including the
parts of thebrain involvesinwakefulness.
decreased libido,
impotence
HEMATOLOGIC:
Hemolytic anemia,
hypoplasticanemia,thrombocytopenia,leucopenia,
agranulocytosis,pancytopenia.
RESPIRATORY:Thickening of
brochial secretions,chest tightness, dry
mouth, suppressionof cough reflex,
potential foraspiration.